Tau phosphorylation in neuronal cell function and dysfunction
Author:
Johnson Gail V. W.1, Stoothoff William H.1
Affiliation:
1. Department of Psychiatry, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA
Abstract
Tau is a group of neuronal microtubule-associated proteins that are formed by alternative mRNA splicing and accumulate in neurofibrillary tangles in Alzheimer's disease (AD) brain. Tau plays a key role in regulating microtubule dynamics, axonal transport and neurite outgrowth, and all these functions of tau are modulated by site-specific phosphorylation. There is significant evidence that a disruption of normal phosphorylation events results in tau dysfunction in neurodegenerative diseases, such as AD, and is a contributing factor to the pathogenic processes. Indeed, the abnormal tau phosphorylation that occurs in neurodegenerative conditions not only results in a toxic loss of function (e.g. decreased microtubule binding) but probably also a toxic gain of function (e.g. increased tau-tau interactions). Although tau is phosphorylated in vitro by numerous protein kinases, how many of these actually phosphorylate tau in vivo is unclear. Identification of the protein kinases that phosphorylate tau in vivo in both physiological and pathological processes could provide potential therapeutic targets for the treatment of AD and other neurodegenerative diseases in which there is tau pathology.
Publisher
The Company of Biologists
Reference117 articles.
1. Abraha, A., Ghoshal, N., Gamblin, T. C., Cryns, V., Berry, R. W., Kuret,
J. and Binder, L. I. (2000). C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J. Cell Sci.113, 3737-3745. 2. Agarwal-Mawal, A. and Paudel, H. K. (2001). Neuronal Cdc2-like protein kinase (Cdk5/p25) is associated with protein phosphatase 1 and phosphorylates inhibitor-2. J. Biol. Chem.276, 23712-23718. 3. Ahlijanian, M. K., Barrezueta, N. X., Williams, R. D., Jakowski, A.,
Kowsz, K. P., McCarthy, S., Coskran, T., Carlo, A., Seymour, P. A., Burkhardt, J. E. et al. (2000). Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc. Natl. Acad. Sci. USA97, 2910-2915. 4. Alonso, A. C., Grundke-Iqbal, I. and Iqbal, K. (1996). Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med.2, 783-787. 5. Anderton, B. H., Betts, J., Blackstock, W. P., Brion, J. P., Chapman, S.,
Connell, J., Dayanandan, R., Gallo, J. M., Gibb, G., Hanger, D. P. et al. (2001). Sites of phosphorylation in tau and factors affecting their regulation. Biochem. Soc. Symp.67, 73-80.
Cited by
487 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|